Detalles de la búsqueda
1.
Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing matters.
J Surg Oncol
; 129(2): 244-253, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37800378
2.
The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on response to neoadjuvant therapy.
J Surg Oncol
; 2024 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38801055
3.
Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial.
Cancer Immunol Immunother
; 72(3): 697-705, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36045304
4.
Immunologic and dose dependent effects of rapamycin and its evolving role in chemoprevention.
Clin Immunol
; 245: 109095, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35973640
5.
Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival.
Ann Surg Oncol
; 29(9): 6015-6028, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35583691
6.
Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer.
Clin Immunol
; 225: 108679, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33485895
7.
Correlation of tumor microenvironment from biopsy and resection specimens in untreated colorectal cancer patients: a surprising lack of agreement.
Cancer Immunol Immunother
; 70(5): 1465-1474, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33180182
8.
A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis.
Ann Surg Oncol
; 28(11): 6126-6137, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33641012
9.
An Educational Intervention Reduces Opioids Prescribed Following General Surgery Procedures.
J Surg Res
; 257: 399-405, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32892137
10.
Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence.
Breast Cancer Res Treat
; 181(2): 391-401, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32323103
11.
Initial safety analysis of a randomized phase II trial of nelipepimut-Sâ¯+â¯GM-CSF and trastuzumab compared to trastuzumab alone to prevent recurrence in breast cancer patients with HER2 low-expressing tumors.
Clin Immunol
; 201: 48-54, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30817999
12.
Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39': An analysis of safety and immune response.
Clin Immunol
; 192: 6-13, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29574039
13.
Effects of HLA status and HER2 status on outcomes in breast cancer patients at risk for recurrence - Implications for vaccine trial design.
Clin Immunol
; 195: 28-35, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30025819
14.
Results of a Phase Ib Trial of Combination Immunotherapy with a CD8+ T Cell Eliciting Vaccine and Trastuzumab in Breast Cancer Patients.
Ann Surg Oncol
; 24(8): 2161-2167, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28315060
15.
A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor-dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2.
Cancer Immunol Immunother
; 65(4): 383-92, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26894495
16.
ASO Author Reflections: The Tumor Lysate, Particle-Loaded, Dendritic Cell Vaccine for Advanced-Stage Melanoma: Reflection on Personalized Cancer Vaccination.
Ann Surg Oncol
; 28(11): 6138-6139, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33638047
17.
Injecting Hope--A Review of Breast Cancer Vaccines.
Oncology (Williston Park)
; 30(5): 475-81, 485, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27188680
18.
The development and use of the E75 (HER2 369-377) peptide vaccine.
Future Oncol
; 12(11): 1321-9, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27044454
19.
Improving the outcomes of checkpoint inhibitors in breast cancer.
Lancet Oncol
; 20(3): 316-318, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30765259
20.
Utility of cell-based vaccines as cancer therapy: Systematic review and meta-analysis.
Hum Vaccin Immunother
; 20(1): 2323256, 2024 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38544385